Co-Diagnostics, Inc. Quarterly Liabilities and Equity in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Co-Diagnostics, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2016 to Q2 2024.
  • Co-Diagnostics, Inc. Liabilities and Equity for the quarter ending June 30, 2024 was $80.7M, a 28.5% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $80.7M -$32.1M -28.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $86.7M -$30.3M -25.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $95.3M -$27.8M -22.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $109M -$39.2M -26.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $113M -$48M -29.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $117M -$54.2M -31.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $123M -$36.9M -23.1% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $148M +$42.5M +40.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $161M +$68.1M +73.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $171M +$90M +111% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $160M +$88.8M +125% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $105M +$50.7M +92.8% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $92.8M +$54M +139% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $81.1M +$60.6M +296% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $71.2M +$69M +3116% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $54.7M +$50.8M +1334% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $38.8M +$33.5M +629% Jun 30, 2020 10-Q/A 2020-11-03
Q1 2020 $20.5M +$14.4M +235% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $2.22M +$662K +42.6% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $3.81M +$1.1M +40.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $5.32M +$3.35M +170% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $6.12M +$2.79M +84% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $1.55M -$3.11M -66.7% Dec 31, 2018 10-K 2020-03-30
Q3 2018 $2.71M -$3.34M -55.2% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $1.97M +$1.5M +321% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $3.33M Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $4.66M +$3.37M +260% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $6.05M Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $468K Jun 30, 2017 10-Q 2017-08-25
Q4 2016 $1.3M Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.